Evidence map›Paper›PMID 35419337›Full record

ArticleFrontiers in public health2022

Deep Fungal Infections Among General Hospital Inpatients in Southwestern China: A 5-Year Retrospective Study.

Shu-Ran Wen, Zheng-Hui Yang, Tian-Xiang Dong, Yu-Ye Li, Ying-Kui Cao, Yi-Qun Kuang, Hong-Bin Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mycobiome: an underexplored kingdom in cancer.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. An Unconventional Oral Candidiasis in an Immunocompetent Patient.Journal of fungi (Basel, Switzerland) · 2023
    Article
  13. Biomolecular Insights Into the Antifungal Activity ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shu-Ran WenDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zheng-Hui YangDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Tian-Xiang DongDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yu-Ye LiDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Ying-Kui CaoDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yi-Qun KuangNHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China.
Hong-Bin LiDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
First Affiliated Hospital of Kunming Medical University · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deep fungal infection is a type of life-threatening opportunistic infection. Its incidence has been increasing in recent years. This infection can affect the prognosis of patients, prolong hospital stays and raise costs for patients and their families. Objective: We aimed to understand the current situation of deep fungal infections in the First Affiliated Hospital of Kunming Medical University and to provide a basis for the clinical diagnosis and treatment of deep fungal infections. Methods: This was a retrospective analysis of 528,743 cases in the hospital from 2015 to 2019, including the epidemiological characteristics, treatment and prognosis of deep fungal infections. Results: A total of 274 cases (0.05%) with deep fungal infections were identified, accounting for 0.05% of the total number of hospitalizations. The incidence of deep fungal infections in the hospital showed an increasing trend from 2015 to 2019. The most commonly infected site was the respiratory tract (93.07%). Among patients with deep fungal infections, 266 specimens were positive for fungal culture, by which 161 cultured Conclusions: We report for the first time the epidemiological data of deep fungal infections in a general hospital in southwestern China from 2015 to 2019. In the past 5 years, the number of patients with deep fungal infections in the First Affiliated Hospital of Kunming Medical University has been increasing. Although the clinical data are limited, these results can provide references for the diagnosis and treatment of deep fungal infections.

Indexed as

Hospitals, GeneralMycosesHumansIncidenceInpatientsRetrospective StudiesChinadeep fungal infectionsepidemiologygeneral hospitalretrospective study

Identifiers

PMID35419337
PMCPMC8995797
OpenAlexW4220714733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.